Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurotensins and their therapeutic potential: research field study.
Kan Yeung AW, Georgieva MG, Kirilov K, Balacheva AA, Peeva MI, Horbańczuk OK, Horbańczuk JO, Lucarini M, Durazzo A, Santini A, Souto EB, Pajpanova TI, Milella L, Atanasov AG, Tzvetkov NT. Kan Yeung AW, et al. Among authors: kirilov k. Future Med Chem. 2020 Oct;12(19):1779-1803. doi: 10.4155/fmc-2020-0124. Epub 2020 Oct 9. Future Med Chem. 2020. PMID: 33032465 Review.
Neurotensin(8-13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease.
Kühl T, Georgieva MG, Hübner H, Lazarova M, Vogel M, Haas B, Peeva MI, Balacheva AA, Bogdanov IP, Milella L, Ponticelli M, Garev T, Faraone I, Detcheva R, Minchev B, Petkova-Kirova P, Tancheva L, Kalfin R, Atanasov AG, Antonov L, Pajpanova TI, Kirilov K, Gastreich M, Gmeiner P, Imhof D, Tzvetkov NT. Kühl T, et al. Among authors: kirilov k. Eur J Med Chem. 2023 Jun 5;254:115386. doi: 10.1016/j.ejmech.2023.115386. Epub 2023 Apr 17. Eur J Med Chem. 2023. PMID: 37094450
New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity.
Lazarova MI, Tsekova DS, Tancheva LP, Kirilov KT, Uzunova DN, Vezenkov LT, Tsvetanova ER, Alexandrova AV, Georgieva AP, Gavrilova PT, Dragomanova ST, Papazova MG, Handzhiyski YS, Kalfin RE. Lazarova MI, et al. Among authors: kirilov kt. J Alzheimers Dis. 2021;83(3):1211-1220. doi: 10.3233/JAD-210577. J Alzheimers Dis. 2021. PMID: 34420968
Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study.
Kamenov Z, Pehlivanova V, Kuneva T, Kirilov K, Bobeva R, Stoykova J, Mihalevska S. Kamenov Z, et al. Among authors: kirilov k. Diabetes Ther. 2021 Mar;12(3):913-930. doi: 10.1007/s13300-021-01022-0. Epub 2021 Feb 19. Diabetes Ther. 2021. PMID: 33604804 Free PMC article.
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
Cannon CP, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Masiukiewicz U, Charbonnel B, Frederich R, Gallo S, Cosentino F, Shih WJ, Gantz I, Terra SG, Cherney DZI, McGuire DK; VERTIS CV Investigators. Cannon CP, et al. N Engl J Med. 2020 Oct 8;383(15):1425-1435. doi: 10.1056/NEJMoa2004967. Epub 2020 Sep 23. N Engl J Med. 2020. PMID: 32966714 Clinical Trial.
13 results